Difficulty: Medium
Average Score: 80%
Practice
A 70-year-old man has bothersome lower urinary tract syndrome (LUTS) associated with benign prostatic hyperplasia (BPH). His symptoms are no longer well managed with lifestyle modifications. He is interested in medication to reduce his urinary symptoms but is concerned about possible side effects. He notes that he is recently married and sexual activity is very important to him. Which of the following medications would be most appropriate for this patient?
Correct answer
D
Rationale
The most appropriate medication for the 70-year-old man with bothersome lower urinary tract symptoms associated with benign prostatic hyperplasia (BPH), who values sexual activity, is Tamsulosin (Option D). Tamsulosin is a selective alpha-1 blocker that primarily targets the alpha-1A receptors in the prostate, leading to relaxation of smooth muscle in the bladder neck and prostate, improving urine flow without affecting sexual function significantly.
Alfuzosin (Option A) is another alpha-1 blocker used in BPH, but it has a higher incidence of ejaculatory dysfunction compared to Tamsulosin. Ditropan (Option B) is an anticholinergic medication used for overactive bladder, not for BPH. Dutasteride (Option C) is a 5-alpha reductase inhibitor used to reduce prostate size and symptoms in BPH but may lead to sexual side effects like decreased libido and erectile dysfunction.
In an educational context, it is crucial for healthcare providers to consider not only the efficacy of medications but also their potential impact on patients' quality of life and preferences, especially in conditions like BPH where sexual function can be affected. Patient-centered care involves discussing treatment options, including potential side effects, and tailoring therapy to individual patient needs and goals.
Alfuzosin (Option A) is another alpha-1 blocker used in BPH, but it has a higher incidence of ejaculatory dysfunction compared to Tamsulosin. Ditropan (Option B) is an anticholinergic medication used for overactive bladder, not for BPH. Dutasteride (Option C) is a 5-alpha reductase inhibitor used to reduce prostate size and symptoms in BPH but may lead to sexual side effects like decreased libido and erectile dysfunction.
In an educational context, it is crucial for healthcare providers to consider not only the efficacy of medications but also their potential impact on patients' quality of life and preferences, especially in conditions like BPH where sexual function can be affected. Patient-centered care involves discussing treatment options, including potential side effects, and tailoring therapy to individual patient needs and goals.